´ÜÀÏ¿°±â´ÙÇü¼º(SNP) Áö³ëŸÀÌÇÎ ½ÃÀå : ±â¼úº°, ¿ëµµº°, Áö¿ªº°(2025-2033³â)
Single Nucleotide Polymorphism Genotyping Market Report by Technology, Application, and Region 2025-2033
»óǰÄÚµå : 1675397
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 139 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,339,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,786,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,233,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ´ÜÀÏ¿°±â´ÙÇü¼º(SNP) Áö³ëŸÀÌÇÎ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 113¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 423¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³â¿¡ 15.00%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. À¯ÀüÀÚÇüÀÇ ¿¬±¸°³¹ß Ȱµ¿ÀÇ ¹ßÀü, ¸ÂÃãÇü ÀÇ·á ¹× ½Å±Ô ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, µ¿½Ä¹° »ç·á¿¡¼­ À¯ÀüÀÚ ºÐ¼® ¼ö¿äÀÇ Áõ°¡°¡ ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺθ¦ ³ªÅ¸³»°í ÀÖ½À´Ï´Ù.

´ÜÀÏ¿°±â´ÙÇü¼º(SNP) À¯ÀüÇü ºÐ¼®Àº µ¥¿Á½Ã¸®º¸ÇÙ»ê(DNA) ¿°±â¼­¿­ÀÇ Æ¯Á¤ À§Ä¡¸¦ Á¶»çÇÏ¿© °³ÀÎ °£ À¯ÀüÀû º¯À̸¦ ½Äº°ÇÏ°í ºÐ¼®Çϱâ À§ÇØ °í¾ÈµÈ ±â¼úÀÔ´Ï´Ù. ÀÌ´Â °³ÀÎÀÇ DNA³» ƯÁ¤ SNP ºÎÀ§¿¡ Á¸ÀçÇϴ ƯÁ¤ ´ºÅ¬·¹¿ÀƼµå¸¦ °áÁ¤ÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR) ¹× DNA ¿°±â¼­¿­ ºÐ¼®°ú °°Àº ÷´Ü ºÐÀÚ»ý¹°ÇÐÀû ±â¼ú¿¡ ÀÇÁ¸Çϸç, PCRÀ» ÅëÇØ SNP¸¦ Æ÷ÇÔÇÑ DNA ´ÜÆíÀ» ÁõÆøÇϰí, ÁõÆøµÈ DNA¸¦ Á÷Á¢ ¿°±â¼­¿­ ºÐ¼®Çϰųª ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ¹× ´ë¸³À¯ÀüÀÚ Æ¯ÀÌÀû PCR°ú °°Àº ´Ù¸¥ ¹æ¹ýÀ» »ç¿ëÇÏ¿© SNP ºÎÀ§ÀÇ ´ºÅ¬·¹¿ÀƼµå¸¦ °áÁ¤ÇÕ´Ï´Ù. Áý´Ü À¯ÀüÇÐ, À̵¿ ÆÐÅÏ, ÁøÈ­ ¿ª»ç¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. SNP À¯Àüü ºÐ¼®Àº º¹ÀâÇÑ Áúº´ÀÇ À¯ÀüÀû ±âÃʸ¦ ¿¬±¸Çϰí, À¯ÀüÀû À§Çè ¿äÀÎÀ» ½Äº°Çϰí, Çâ»óµÈ Áø´Ü ÅøÀ» °³¹ßÇϱâ À§ÇØ ¿¬±¸ÀÚµéÀÌ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸Àڵ鿡 ÀÇÇØ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

´ÜÀÏ¿°±â´ÙÇü¼º(SNP) À¯ÀüÇü ºÐ¼® ½ÃÀå µ¿Çâ :

ÇöÀç ´Ù¾çÇÑ Áúº´ÀÇ Áø´Ü Åø ¹× È¿°úÀûÀÎ Ä¡·á¹ý °³¹ß¿¡ ÀÖÀ¸¸ç, À¯ÀüÇü ¿¬±¸°³¹ß Ȱµ¿°ú ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º Áõ°¡¸¦ ¹è°æÀ¸·Î SNP À¯ÀüÇü ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» Áö¿øÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ¾Ï, ½ÉÇ÷°ü, ¾ËÃ÷ÇÏÀ̸Ӻ´, õ½Ä µî ´Ù¾çÇÑ Àΰ£ ÁúȯÀÇ º´Àο¡¼­ SNP À¯ÀüÇü ºÐ¼®ÀÇ È°¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ À¯ÀüÀû °ü°èÀÇ È®¸³, ºÎÀÚ°ü°è ºÐÀï ÇØ°á, ¹üÁË ¼ö»ç Áö¿ø µîÀ» ¸ñÀûÀ¸·Î ÇÏ´Â SNP À¯ÀüÇü ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä°¡ Àü ¼¼°è¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̴ Ȱ¹ßÇÑ ÀÇ·á »ê¾÷°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á ¹× »õ·Î¿î ¾à¹°Àü´Þ ½Ã½ºÅÛÀ» À§ÇÑ ÆÄÀÌÇÁ¶óÀÎ Áõ°¡·Î ÀÎÇÑ ¾à¹°À¯ÀüüÇп¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î ³ó¾÷ »ý¸í°øÇÐ, Áø´Ü ¿¬±¸, Á¦¾à, ¾à¹°À¯ÀüüÇÐ, µ¿¹° ¹× °¡Ãà ¹ø½Ä µî »ý¸í°úÇÐ ºÐ¾ß¿¡¼­ SNP À¯ÀüÇüÁú ºÐ¼®ÀÇ ´Ù¾çÇÑ ±â¼úÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó Àü ¼¼°è¿¡¼­ ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, ¾ÏÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¿¹° ¹× ½Ä¹° »ç·á ¿ø·áÀÇ À¯ÀüÀÚ ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ´ÜÀÏ¿°±â´ÙÇü¼º(SNP) Áö³ëŸÀÌÇÎ ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : ±â¼úº°

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

Á¦8Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦9Àå ÃËÁø¿äÀΡ¤¾ïÁ¦¿äÀΡ¤±âȸ

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå Porter's Five Forces ºÐ¼®

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global single nucleotide polymorphism (SNP) genotyping market size reached USD 11.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.3 Billion by 2033, exhibiting a growth rate (CAGR) of 15.00% during 2025-2033. The growing genotype research and development activities, rising demand for personalized medicine and novel drug delivery systems, and increasing demand for genetic analysis in animal and plant feedstock represent some of the key factors driving the market.

Single nucleotide polymorphism (SNP) genotyping is a technique designed to identify and analyze genetic variations among individuals by examining specific locations within their deoxyribonucleic acid (DNA) sequence. It involves determining the specific nucleotide present at a particular SNP site in the DNA of an individual. It relies on advanced molecular biology techniques, such as polymerase chain reaction (PCR) and DNA sequencing, wherein PCR amplifies the DNA segment containing the SNP, and then the nucleotide at the SNP site is determined either by directly sequencing the amplified DNA or using other methods like microarrays or allele-specific PCR. It aids in understanding population genetics, migration patterns, and evolutionary history. It plays a crucial role in determining response to medications, predicting disease susceptibility, and tailoring treatments to specific genetic profiles. SNP genotyping is used by researchers to study the genetic basis of complex diseases, identify genetic risk factors, and develop enhanced diagnostic tools.

Single Nucleotide Polymorphism (SNP) Genotyping Market Trends:

At present, the increasing demand for SNP genotyping on account of the rising genotype research and development activities and bioinformatics in the development of diagnostic tools or effective therapeutics for various diseases represents one of the crucial factors supporting the growth of the market. In addition, the growing utilization of SNP genotyping in the etiology of various human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, is offering a favorable market outlook. Besides this, there is a rise in the demand for SNP genotyping to establish genetic relationships, resolve paternity disputes, and assist in criminal investigations around the world. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the increasing demand for pharmacogenomics due to the rising pipeline for personalized medicine and novel drug delivery systems is strengthening the growth of the market. Apart from this, numerous technologies of SNP genotyping in the life science field, such as agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal and livestock breeding, are contributing to the growth of the market. In line with this, the growing prevalence of diabetes, cardiovascular diseases, and cancer across the globe is positively influencing the market. Furthermore, the rising demand for genetic analysis in animal and plant feedstock is bolstering the growth of the market.

Key Market Segmentation:

Technology Insights:

Application Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Single Nucleotide Polymorphism (SNP) Genotyping Market

6 Market Breakup by Technology

7 Market Breakup by Application

8 Market Breakup by Region

9 Drivers, Restraints, and Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â